MDT

100.48

+1.87%↑

A

139.65

+3%↑

VEEV

219.8

+1.79%↑

HQY

84.32

+0.78%↑

NEOG

9.86

+5.45%↑

MDT

100.48

+1.87%↑

A

139.65

+3%↑

VEEV

219.8

+1.79%↑

HQY

84.32

+0.78%↑

NEOG

9.86

+5.45%↑

MDT

100.48

+1.87%↑

A

139.65

+3%↑

VEEV

219.8

+1.79%↑

HQY

84.32

+0.78%↑

NEOG

9.86

+5.45%↑

MDT

100.48

+1.87%↑

A

139.65

+3%↑

VEEV

219.8

+1.79%↑

HQY

84.32

+0.78%↑

NEOG

9.86

+5.45%↑

MDT

100.48

+1.87%↑

A

139.65

+3%↑

VEEV

219.8

+1.79%↑

HQY

84.32

+0.78%↑

NEOG

9.86

+5.45%↑

Search

Alcon Inc

Ouvert

SecteurSoins de santé

81.71 0.75

Résumé

Variation du prix de l'action

24h

Actuel

Min

80.77

Max

81.94

Chiffres clés

By Trading Economics

Revenu

55M

238M

Ventes

18M

2.6B

P/E

Moyenne du Secteur

37.619

89.037

Rendement du dividende

0.42

Marge bénéficiaire

9.11

Employés

25,000

EBITDA

415M

665M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+15.72% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

0.42%

2.18%

Prochains Résultats

24 févr. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

2.2B

39B

Ouverture précédente

80.96

Clôture précédente

81.71

Sentiment de l'Actualité

By Acuity

25%

75%

66 / 360 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Bullish Evidence

Alcon Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

6 janv. 2026, 15:11 UTC

Acquisitions, Fusions, Rachats

Staar Surgical Shareholders Reject $1.6 Billion Acquisition by Alcon in Activist Win

9 déc. 2025, 18:51 UTC

Acquisitions, Fusions, Rachats

Broadwood Partners Still Opposes Alcon's Higher Bid for Staar Surgical

9 déc. 2025, 15:54 UTC

Principaux Mouvements du Marché
Acquisitions, Fusions, Rachats

Staar Surgical Shares Surge as Alcon Boosts its Buyout Price

9 déc. 2025, 14:32 UTC

Acquisitions, Fusions, Rachats

Alcon Upgrades Offer Price for Staar Surgical

12 nov. 2025, 09:09 UTC

Résultats
Principaux Mouvements du Marché

Alcon Shares in Switzerland Climb After Guidance Confirmation

7 janv. 2026, 01:00 UTC

Acquisitions, Fusions, Rachats

Alcon Terminates Agreement To Acquire STAAR Surgical >ALC

6 janv. 2026, 22:03 UTC

Acquisitions, Fusions, Rachats

Staar Surgical: Merger Proposal Received 14.9M Votes For and 27.3M Against

6 janv. 2026, 22:03 UTC

Acquisitions, Fusions, Rachats

Staar Surgical, Which Earlier Reported Stockholder Rejection of Sale to Alcon, Reports Vote Totals

6 janv. 2026, 15:21 UTC

Market Talk
Acquisitions, Fusions, Rachats

Staar May See Management Turnover After Alcon Bid Is Rejected -- Market Talk

6 janv. 2026, 14:56 UTC

Acquisitions, Fusions, Rachats

Staar Surgical Shareholders Reject $1.6B Acquisition by Alcon in Activist Win

6 janv. 2026, 14:14 UTC

Acquisitions, Fusions, Rachats

Staar Surgical: Will Remain a Standalone, Publicly Traded Co and Continue to Trade on Nasdaq >STAA

6 janv. 2026, 14:14 UTC

Acquisitions, Fusions, Rachats

Staar Surgical: No Termination Fee Will Be Payable by Either Party >STAA

6 janv. 2026, 14:14 UTC

Acquisitions, Fusions, Rachats

Staar Surgical: Intend to Terminate Merger Agreement With Alcon >STAA

6 janv. 2026, 14:13 UTC

Acquisitions, Fusions, Rachats

Staar Surgical: Did Not Receive Necessary Stockholder Votes to Approve Merger Agreement With Alcon >STAA

9 déc. 2025, 14:17 UTC

Acquisitions, Fusions, Rachats

Alcon Ups Offer Price for Staar Surgical

9 déc. 2025, 13:34 UTC

Acquisitions, Fusions, Rachats

Alcon: Transaction Now Represents a Total Equity Value of $1.6B >ALC.EB

9 déc. 2025, 13:33 UTC

Acquisitions, Fusions, Rachats

Alcon: Purchase Price Increase Represents an Additional $150M >ALC.EB

9 déc. 2025, 13:33 UTC

Acquisitions, Fusions, Rachats

Alcon: Under the Terms of the Amended Agreement, Alcon Will Purchase All Outstanding Shrs of STAAR for $30.75 Per Shr in Cash >ALC.EB

9 déc. 2025, 13:33 UTC

Acquisitions, Fusions, Rachats

Alcon To Finance Transaction Through Issuance of Short- and Long-Term Credit Facilities >ALC

9 déc. 2025, 13:32 UTC

Acquisitions, Fusions, Rachats

Alcon: "Go-shop" Window Expired on Dec 6 >ALC.EB

9 déc. 2025, 13:32 UTC

Acquisitions, Fusions, Rachats

Alcon: Transaction Now Represents Total Equity Value of About $1.6B >ALC

9 déc. 2025, 13:31 UTC

Acquisitions, Fusions, Rachats

Alcon Will Purchase All Outstanding Shrs of STAAR for $30.75 Per Shr in Cash >ALC

9 déc. 2025, 13:31 UTC

Acquisitions, Fusions, Rachats

Alcon Announces Amended Merger Agreement With STAAR Surgical

9 déc. 2025, 13:31 UTC

Acquisitions, Fusions, Rachats

Alcon Enters Amended Merger Agreement for Acquisition of STAAR Surgical >ALC

12 nov. 2025, 08:46 UTC

Market Talk

Alcon's Guidance Reiteration Offers Relief -- Market Talk

11 nov. 2025, 21:35 UTC

Résultats

Alcon 3Q Adj EPS 79c >ALC

11 nov. 2025, 21:35 UTC

Résultats

Alcon 3Q Rev $2.61B >ALC.EB

11 nov. 2025, 21:35 UTC

Résultats

Alcon Backs 2025 EPS $3.05-EPS $3.15 >ALC.EB

11 nov. 2025, 21:35 UTC

Résultats

Alcon 3Q EPS 48c >ALC.EB

11 nov. 2025, 21:34 UTC

Résultats

Alcon Backs 2025 Adj EPS $3.05-Adj EPS $3.15 >ALC

Comparaison

Variation de prix

Alcon Inc prévision

Objectif de Prix

By TipRanks

15.72% hausse

Prévisions sur 12 Mois

Moyen 91.49 USD  15.72%

Haut 112.534 USD

Bas 75.023 USD

Basé sur 12 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

12 ratings

7

Achat

4

Maintien

1

Vente

Score Technique

By Trading Central

95.77 / 97.61Support & Résistance

Court Terme

Bullish Evidence

Moyen Terme

Strong Bullish Evidence

Long Terme

Strong Bullish Evidence

Sentiment

By Acuity

66 / 360Classement par Soins de santé

Sentiment de l'Actualité

Très Fortes Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Alcon Inc

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, ARGOS biometer, LuxOR surgical ophthalmic microscope, SMARTCATARACT health platform, NGENUITY 3D visualization system, Verion reference unit and Verion digital marker, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantable products, including AcrySof IQ products, such as monofocal IOLs and advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
help-icon Live chat